Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The DNA methylome of cervical cells and risk of ovarian cancer

ABSTRACT: The WID-OC-index identifies women with ovarian cancer based on a DNA methylation signature derived from cervical smear samples (a total of 289 ovarian cancer samples were included)

PROVIDER: EGAS00001005045 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Epigenome analysis of normal and preinvasive cervical smear samples

Project description:Genome wide DNA methylation profiling of normal and preinvasive cervical smear samples infected with the human papilloma virus (HPV) The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs in liquid based cytology (LBC) cervical smear samples. Samples included 19 normal smears without HPV, 11 normal smears with HPV infection, and 18 smears with HPV and exhibiting dysplasia. email: a.teschendorff@ucl.ac.uk Keywords: DNA methylation

2010-03-01 | GSE20080 | GEO

Epigenome analysis of normal and preinvasive cervical smear samples

2010-05-06 | E-GEOD-20080 | biostudies-arrayexpress

The WID-EC test for the detection and risk prediction of endometrial cancer

Project description:The WID-EC-index identifies women with endometrial cancer based on a DNA methylation signature derived from cervical smear samples (a total of 281 endometrial cancer samples were included).

| EGAS00001005033 | EGA

DNA methylome and transcriptome profiles in carboplatin-sensitive and -resistant ovarian cancer cell lines [RNA-seq]

Project description:Genetic and epigenetic changes contribute to intratumor heterogeneity and chemotherapy resistance in several tumor types. LncRNAs have been implicated, directly or indirectly, in the epigenetic regulation of gene expression. We investigated lncRNAs that potentially mediate carboplatin-resistance of cell subpopulations, influencing the progression of ovarian cancer (OC). Four carboplatin-sensitive OC cell lines (IGROV1, OVCAR3, OVCAR4, and OVCAR5), their derivative resistant cells, and two inherently carboplatin-resistant cell lines (OVCAR8 and Ovc316) were subjected to RNA-sequencing and global DNA methylation analysis. Integrative and cross-validation analyses were performed using external (The Cancer Genome Atlas, TCGA dataset, n=111 OC samples) and internal datasets (n=39 OC samples) to identify lncRNA candidates. A total of 4,255 differentially expressed genes (DEGs) and 14,529 differentially methylated CpG positions (DMPs) were identified comparing sensitive and resistant OC cell lines. The comparison of DEGs between OC cell lines and TCGA-OC dataset revealed 570 genes, including 50 lncRNAs, associated with carboplatin resistance. Eleven lncRNAs showed DMPs, including the SNHG12. Knockdown of SNHG12 in Ovc316 and OVCAR8 cells increased their sensitivity to carboplatin. The results suggest that the lncRNA SNHG12 contributes to carboplatin resistance in OC and is a potential therapeutic target. We demonstrated that SNHG12 is functionally related to epigenetic mechanisms.

2022-04-20 | GSE198042 | GEO

DNA methylome and transcriptome profiles in carboplatin-sensitive and -resistant ovarian cancer cell lines [methylation array]

2022-04-20 | GSE198073 | GEO

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

Project description:A surrogate marker based on the epigenome that captures these components in easily accessible epithelial tissue could potentially identify women at risk. The WID-BC-index identifies women with breast cancer based on a DNA methylation signature derived from cervical smear samples.

| EGAS00001005055 | EGA

Proteomics of cervical mucus in natural and stimulated cycle

Project description:Cervical mucus is a viscous fluid functioning as a uterine cervix plug. It is formed and produced by cervical glands located in the cervix. During ovulation, cervical mucus starts to become less viscous, which is a good window for non-invasive sampling. Our study focuses on the proteomic characterization of cervical mucus, which may thus act as a non-invasively acquired source of biomarkers for diseases and physiological conditions of the female genital tract. Our study aimed at two aims - the first is to optimize a proteomic workflow of cervical mucus processing. The second aim is to assess differences in the proteomic composition of cervical mucus in natural ovulatory cycles and IVF cycles with controlled ovarian hyperstimulation. The sampling was done in cooperation with women undergoing intrauterine insemination in a natural ovulatory cycle and women undergoing controlled ovarian hyperstimulation for IVF. The optimization of proteomic workflow including an analysis on an Orbitrap mass spectrometer was performed. The results revealed the protein composition and the differences of the cervical mucus between natural and stimulated uterus.

2023-03-10 | PXD037654 | Pride

: Pap test, cervical swab, and tumor tissue LC-MS/MS proteomics from a case of high grade serous ovarian cancer.

Project description:The aim of this study was to determine whether the residual fixative from a liquid-based Pap test or a swab of the cervix contained proteins that were also found in the primary tumor of a woman with high grade serous ovarian cancer. A total of 4,934 proteins were identified and analyzed. This study is the first step in determining the feasibility of using the liquid-based Pap test or a cervical swab for the detection of ovarian cancer biomarkers

2021-01-12 | PXD023272 | Pride

Serum miRNA as Potential Biomarkers for ovarian cancer

Project description:Serum samples were obtained from patients with ovarian cancer (OC; n=64) and noncancerous control (n=4) for microarray. We found that four miRNAs were significantly high-expression level in OC relative to the controls.

2023-04-27 | GSE201712 | GEO

Detection of cervical intraepithelial neoplasia and HPV infection in women with inflammatory bowel disease

Project description:Interventions: Group 1: A PAP smear and HPV will be taken in women with inflammatory bowel disease Primary outcome(s): Frequency of Cervical intraepithelial neoplasia and human paplloma Virus in women with inflammatory bowel disease Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: diagnostic

| 2431908 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data